Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway | |
Li D.; Wang W.-J.; Wang Y.-Z.; Wang Y.-B.; Li Y.-L. | |
刊名 | Cell Death and Disease |
2019 | |
卷号 | 10期号:10 |
DOI | 10.1038/s41419-019-1918-1 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4554028 |
专题 | 山东大学 |
作者单位 | 1.Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China 2.Department of Interventional Med |
推荐引用方式 GB/T 7714 | Li D.,Wang W.-J.,Wang Y.-Z.,et al. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway[J]. Cell Death and Disease,2019,10(10). |
APA | Li D.,Wang W.-J.,Wang Y.-Z.,Wang Y.-B.,&Li Y.-L..(2019).Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway.Cell Death and Disease,10(10). |
MLA | Li D.,et al."Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway".Cell Death and Disease 10.10(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论